Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

Duchenne's Muscular Dystrophy Clinical Trial

Official title: Allogeneic Transplantation of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

Status Completed

Clinical Trial Summary

This research study is designed to evaluate the effects of human umbilical cord mesenchymal stem cells (UC-MSCs), on Duchenne's muscular dystrophy (DMD). The potential muscle regenerative and anti-inflammatory properties of UC MSCs position them as a possible treatment option for DMD. Both of these properties could lead to potential benefits for a DMD patient.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Duchenne's Muscular Dystrophy
• Muscular Dystrophies
• Muscular Dystrophy, Duchenne

• NCT number: NCT02235844
• Study type: Interventional
• Source: Allergy and Asthma Consultants, Wichita, Kansas
• Status: Completed
• Phase: Phase 1
• Start date: September 2014
• Completion date: September 30, 2017